Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

PROGRAM CHAIR

Craig Leonardi, MD
Central Dermatology
St. Louis, Missouri, United States
IPC President

Dr. Leonardi is Adjunct Professor of Dermatology at St. Louis University Medical School in St. Louis, Missouri, where he also has a private practice. He received his medical degree from the University of Miami School of Medicine in Florida and completed an internship in pediatrics and residency in dermatology at the University of Miami/Jackson Memorial Hospital.

Dr. Leonardi is certified by the American Board of Dermatology. He is a fellow of the American Academy of Dermatology and member of the American Dermatological Association. He is a co-founder and president of the International Psoriasis Council. He is a member of the National Psoriasis Foundation’s medical advisory board.

Dr. Leonardi has extensive experience using the new biologics in the treatment of psoriasis. He has been an invited speaker at national, regional, and state venues and serves on the advisory boards of several pharmaceutical companies. He has been involved in more than 200 clinical trials and has published more than 250 original articles and abstracts in such journals as the Journal of the American Academy of Dermatology, the British Journal of Dermatology, the Archives of Dermatology, the Journal of the American Medical Association, the New England Journal of Medicine, and the Lancet. He is a member of the American Academy of Dermatology Psoriasis Guidelines committee.

Last Updated: Feb 01, 2022

 

PROGRAM FACULTY

Andrew Blauvelt, MD, MBA
Oregon Medical Research Center
Portland, Oregon, United States
IPC Board Member

Dr. Blauvelt is President of Oregon Medical Research Center, a small business dedicated to performing high quality clinical research studies in dermatology. He received his undergraduate degree in electrical engineering at Purdue University, his medical degree at Michigan State University, and a healthcare MBA at Oregon Health & Science University (OHSU). Dr. Blauvelt trained in dermatology at the University of Miami and in cellular immunology under the direction of Steve Katz at the National Institutes of Health (NIH). Earlier in his career, he held senior staff positions at the NIH (Senior Investigator), OHSU (Professor), and the Portland VA Medical Center (Chief). Dr. Blauvelt's research and clinical expertise has been in Langerhans cell biology, T cell immunology, virology, psoriasis, and atopic dermatitis. He has published over 300 papers and spoken across the country and world on these topics. Within psoriasis research, his laboratory published key papers on the role of IL-23/Th17 biology in psoriasis; in recent years, he has been the international lead investigator on a number of important clinical trials, including PSTELLAR, FEATURE, IXORA-R, VOYAGE 1, IMMhance, CHRONOS, ECZTEND, JADE REGIMEN, and HEADS UP. Dr. Blauvelt is also an elected member of the American Society for Clinical Investigation, the International Psoriasis Council, the International Eczema Council, and the Scientific Advisory Committee of the National Psoriasis Foundation. In 2021, he made the list of Highly Cited Researchers, representing the top 1% of cited scientists in the world.

Last Updated: Jan 26, 2022

Charles Lynde, MD, FRCPC, DABD, FCDA
Lynde Institute for Dermatology & Lynderm Research
Markham, Ontario, Canada

Dr. Charles Lynde is an Associate Professor in the Department of Medicine at the University of Toronto and holds a clinical teaching position at the University Health Network. He is the Medical Director of Lynde Institute for Dermatology and Lynderm Research. The Lynde Institute for Dermatology is a full service, interdisciplinary dermatology clinic. After receiving his B.Sc. and MD, degrees at the University of Toronto, Dr. Lynde studied Dermatology at the University of British Columbia and the University of Toronto, receiving his Board Certification (Canada and USA) in 1983.

Lynderm Research is under the guidance of Dr. Lynde as principal investigator for more than 30 years and over 300 clinical trials and is actively involved in the management of psoriasis, rosacea, onychomycosis, acne and atopic dermatitis among other dermatological conditions. Dr. Lynde has authored over 200 peer-reviewed articles.

Dr. Lynde has served in various roles for the CDA and AAD, including President of the Canadian Dermatology Association. He is the Editor of the CDA eBulletin and sits on the editorial boards of several journals and provides extensive consulting as well as being on the advisory boards of many pharmaceutical companies.

Last Updated: Nov 30, 2021

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK